Correction: Clinical efficacy and safety of interferon (Type I and Type III) therapy in patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials
- PMID: 38100457
- PMCID: PMC10723685
- DOI: 10.1371/journal.pone.0296219
Correction: Clinical efficacy and safety of interferon (Type I and Type III) therapy in patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0272826.].
Copyright: © 2023 Ryoo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Erratum for
-
Clinical efficacy and safety of interferon (Type I and Type III) therapy in patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials.PLoS One. 2023 Mar 29;18(3):e0272826. doi: 10.1371/journal.pone.0272826. eCollection 2023. PLoS One. 2023. PMID: 36989209 Free PMC article.
References
-
- Ryoo S, Koh D-H, Yu S-Y, Choi M, Huh K, Yeom J-S, et al. (2023) Clinical efficacy and safety of interferon (Type I and Type III) therapy in patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials. PLoS ONE 18(3): e0272826. 10.1371/journal.pone.0272826 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
